Is Challenger now a takeover target?

Will the Challenger Ltd (ASX:CGF) share price run higher in 2019?

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Challenger Ltd (ASX: CGF) share price climbed 9% to $7.92 this afternoon as the annuities manager announced its Japanese partner Mitsui Sumitomo had lifted its equity holding in the business to more than 15% and wanted a seat on its board of directors as a result.

As such some may think its powerful Japanese partner might eventually launch a full takeover bid for the Australian annuities manager with it making sense for it to try sooner, rather than later, given Challenger's valuation has fallen on the back of a couple of soft profit reports recently.

Mitsui will also provide Challenger annual reinsurance amounts across both US and Australian dollar denominated annuities worth $640 million per year for at least 5 years.

Challenger also reinsures annuity products issued by Mitsui Sumitomo as a ceding insurer enjoys powerful balance sheet benefits in terms of investment risk and capital adequacy requirements.

In other words if investment capital or assets on the balance sheet are de-risked, then the proportion of risk weighted capital required to be held idly in reserve is lowered in a result that helps improve return on equity as a key measure of profitability.

Despite today's rise Challenger stock is still down around 30% in just one year.

Motley Fool contributor Tom Richardson owns shares of Challenger Limited. You can find Tom on Twitter @tommyr345 The Motley Fool Australia owns shares of and has recommended Challenger Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Gainers

Man drawing an upward line on a bar graph symbolising a rising share price.
Share Gainers

Why Latin Resources, Newmont, Nick Scali, and ResMed shares are surging today

These ASX shares are ending the week strongly. But why?

Read more »

Fancy font saying top ten surrounded by gold leaf set against a dark background of glittering stars.
Share Gainers

Here are the top 10 ASX 200 shares today

Let's also take a look at what the various ASX sectors were doing this Wednesday.

Read more »

A young women pumps her fists in excitement after seeing some good news on her laptop.
Share Gainers

Why Argosy Minerals, Immutep, Pointsbet, and Regis Resources shares are racing higher

These shares are having a strong session on Wednesday. But why?

Read more »

Businessman smiles with arms outstretched after receiving good news.
Share Gainers

Here are the top 10 ASX 200 shares today

It was another strong showing from the share market today.

Read more »

A young woman holding her phone smiles broadly and looks excited, after receiving good news.
Share Gainers

Healthco Healthcare, Medadvisor, Ramsay Health Care, and Tamboran shares are rising

These shares are having a strong session. But why?

Read more »

drug capsule opening up to reveal dollar signs signifying rising asx share price
Share Gainers

If you invested $6,000 in Mesoblast shares a month ago you'd have $15,636 now!

Mesoblast shares have been on a tear this past month. But why?

Read more »

Smiling man working on his laptop.
Share Gainers

Here are the top 10 ASX 200 shares today

It was back to the races for ASX shares today, in a confident start to the week.

Read more »

rising gold share price represented by a green arrow on piles of gold block
Share Gainers

Here are the top 10 ASX 200 shares today

It was a horrible way to end the trading week today for ASX investors.

Read more »